These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3724938)

  • 1. [Detection of fibrinolysis in chronic subdural hematoma].
    Trappe A; Hafter R; Wendt P; Graeff H; Blümel G
    Neurochirurgia (Stuttg); 1986 May; 29(3):78-82. PubMed ID: 3724938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M; Kashiwagi S; Pei W; Fujisawa H; Ito H; Nakamura K
    Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma.
    Ito H; Yamamoto S; Komai T; Mizukoshi H
    J Neurosurg; 1976 Jul; 45(1):26-31. PubMed ID: 132513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrhage into tha cavity of chronic subdural hematoma].
    Ito H; Shimoji T; Kimura M; Maeda M; Uehara S; Yamamoto S
    No Shinkei Geka; 1984 Apr; 12(5):563-8. PubMed ID: 6462354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot.
    Nomura S; Kashiwagi S; Fujisawa H; Ito H; Nakamura K
    J Neurosurg; 1994 Dec; 81(6):910-3. PubMed ID: 7965121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
    Graeff H; Klaubert W; Klaubert E; Gollwitzer R; von Hugo R; Hafter R
    Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():42-6. PubMed ID: 6555132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
    Weir B; Gordon P
    J Neurosurg; 1983 Feb; 58(2):242-5. PubMed ID: 6848682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis in chronic subdural hematoma.
    Kawakami Y; Chikama M; Tamiya T; Shimamura Y
    Neurosurgery; 1989 Jul; 25(1):25-9. PubMed ID: 2755576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.